SCHEMBL4980233

SCHEMBL4980233

CCNC(=O)N(S)c1ccc2c(c1)Cc1cc(Br)ccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
RAB9A P51151 3/20 0.38
SRD5A1 P18405 1/20 0.36
SRD5A2 P31213 1/20 0.36
METAP1 P53582 2/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 2/20 0.34
MAPT P10636 1/20 0.34
TDP2 O95551 1/20 0.34
TSHR P16473 1/20 0.34
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
TLR9 Q9NR96 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979173 0.90 NAMPT (0.40) SLC1A3SLC1A2SLC1A1RAB9ASRD5A1
SCHEMBL4979942 0.88 MGLL (0.38) SLC1A3SLC1A2SLC1A1RAB9AMETAP1
SCHEMBL4979475 0.87 MGLL (0.42) SLC1A3SLC1A2SLC1A1RAB9ANAMPT
SCHEMBL3977113 0.87 MGLL (0.42) SLC1A3SLC1A2SLC1A1RAB9ANAMPT
SCHEMBL4984400 0.87 MGLL (0.42) SLC1A3SLC1A2SLC1A1RAB9ANAMPT
SCHEMBL3982025 0.87 MGLL (0.42) SLC1A3SLC1A2SLC1A1RAB9ANAMPT
SCHEMBL4261191 0.87 SLC1A3 (0.40) SLC1A3SLC1A2SLC1A1RAB9ASRD5A1
SCHEMBL4983200 0.86 LMNA (0.43) SLC1A3SLC1A2SLC1A1CYP2C19TSHR
SCHEMBL4979553 0.86 CYP1A2 (0.44) SLC1A3SLC1A2SLC1A1SRD5A1SRD5A2
SCHEMBL4983894 0.86 SLC1A3 (0.39) SLC1A3SLC1A2SLC1A1RAB9ASRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 SLC1A3 1879/4885SLC1A2 2277/4885SLC1A1 1953/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 SLC1A3 1757/4885SLC1A2 2330/4885SLC1A1 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.